Reflections on a community engagement strategy for mass antimalarial drug administration in Cambodia

American Journal of Tropical Medicine and Hygiene

Volumn 98, Issue 1, 2018, Pages 100-104

  Peto, Thomas J ^a,b   Tripura, Rupam ^a,c   Davoeung, Chan ^d   Nguon, Chea ^e   Nou, Sanann ^a   Heng, Chhouen ^a   Kunthea, Pich ^a   Adhikari, Bipin ^a,b   Lim, Renly ^f   James, Nicola ^g   Pell, Christopher ^c,h   Cheah, Phaik Yeong ^a,b,i  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d Department of Provincial Health ^*  (Cambodia)

^e National Center for Parasitology Entomology and Malaria Control   (Cambodia)

^f UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE;

ADVERSE OUTCOME; ARTICLE; ASYMPTOMATIC INFECTION; CAMBODIA; COMMON COLD SYMPTOM; COMMUNITY CARE; DIZZINESS; FATIGUE; HEALTH CARE PLANNING; HUMAN; INFECTION RISK; MALARIA; MALARIA FALCIPARUM; MASS DRUG ADMINISTRATION; NONHUMAN; OUTCOME ASSESSMENT; PARASITE PREVALENCE; PUBLIC HEALTH MESSAGE; PUBLIC HEALTH SERVICE; SOCIAL PARTICIPATION; COMMUNITY PARTICIPATION; EPIDEMIOLOGY; PROCEDURES; PROGRAM DEVELOPMENT; PUBLIC RELATIONS;

ANTIMALARIALS; CAMBODIA; COMMUNITY PARTICIPATION; COMMUNITY-INSTITUTIONAL RELATIONS; HUMANS; MALARIA; MASS DRUG ADMINISTRATION; PROGRAM DEVELOPMENT;

EID: 85040510567     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.17-0428     Document Type: Article

References (22)

1. Ashley EA, et al., 2014. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 371: 411-423.
2. Dondorp AM, Smithuis FM, Woodrow C, Seidlein LV, 2017. How to contain artemisinin-A nd multidrug-resistant falciparum malaria. Trends Parasitol 33: 353-363.
3. World Health Organization, 2014. Accelerating Malaria Elimination in the Greater Mekong Subregion. Available at: Http://www. who.int/malaria/areas/greater-mekong/overview/en/. Accessed July 13, 2017.
4. World Health Organization, 2015. Strategy for Malaria Elimination in the Greater Mekong Subregion (2015-2030). Available at: Http://iris.wpro.who.int/bitstream/handle/10665.1/10945/9789290617181-eng.pdfsequence=1. Accessed July 14, 2017.
5. Sturrock HJ, Hsiang MS, Cohen JM, Smith DL, Greenhouse B, Bousema T, Gosling RD, 2013. Targeting asymptomatic malaria infections: Active surveillance in control and elimination. PLoS Med 10: E1001467.
6. Cantey PT, Rout J, Rao G, Williamson J, Fox LM, 2010. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. PLoS Negl Trop Dis 4: E728.
7. Adhikari B, James N, Newby G, von Seidlein L, White NJ, Day NP, Dondorp AM, Pell C, Cheah PY, 2016. Community engagement and population coverage in mass anti-malarial administrations: A systematic literature review. Malar J 15: 523.
8. Clinical and Translational Sciene Awards (CTSA), 2011. Principles of Community Engagement. NIH Publication No. 11-7782; second edition.
9. Tindana PO, Singh JA, Tracy CS, Upshur RE, Daar AS, Singer PA, Frohlich J, Lavery JV, 2007. Grand challenges in global health: Community engagement in research in developing countries. PLoS Med 4: E273.
10. Maude RJ, et al., 2014. Spatial and temporal epidemiology of clinical malaria in Cambodia 2004-2013. Malar J 13: 385.
11. Phyo AP, et al., 2012. Emergence of artemisinin-resistant malaria on the western border of Thailand: A longitudinal study. Lancet 379: 1960-1966.
12. WHO, 2010. Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000-2010. Geneva, Switzerland: World Health Organization.
13. Dondorp AM, et al., 2009. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455-467.
14. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM; Artemisinin Resistance in Cambodia 1 Study Consortium, 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359: 2619-2620.
15. Durnez L, Mao S, Denis L, Roelants P, Sochantha T, Coosemans M, 2013. Outdoor malaria transmission in forested villages of Cambodia. Malar J 12: 329.
16. Peto TJ, et al., 2016. History of malaria treatment as a predictor of subsequent subclinical parasitaemia: A cross-sectional survey and malaria case records from three villages in Pailin, western Cambodia. Malar J 15: 240.
17. Peto TJ, et al., 2016. Association between subclinical malaria infection and inflammatory host response in a pre-elimination setting. PLoS One 11: E0158656.
18. Imwong M, et al., 2015. The epidemiology of subclinical malaria infections in South-East Asia: Findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam. Malar J 14: 381.
19. Imwong M, et al., 2016. Numerical distributions of parasite densities during asymptomatic malaria. J Infect Dis 213: 1322-1329.
20. Tripura R, et al., 2016. Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: Implications for prevention, treatment and elimination strategies. Malar J 15: 1-12.
21. Tripura R, et al., 2017. Submicroscopic Plasmodium prevalence in relation to malaria incidence in 20 villages in western Cambodia. Malar J 16: 56.
22. Gale NK, Heath G, Cameron E, Rashid S, Redwood S, 2013. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 13: 117.